From: Brenda Umberger [brenda.umberger@nist.gov]
Sent: Monday, November 27, 2006 4:49 PM
To: Dockets, FDA
Cc: anne.meininger@nist.gov
Subject: China comments on proposed rule - Human and Animal Drugs (G/TBT/N/USA/214)

Attachments: China comments-Human & Animal Drugs USA 214.PDF
Dear FDA Docket No. 2005N-0403 (RIN 0910-AA49),

As the U.S. Inquiry Point under the World Trade Organization on Technical Barriers to Trade, we are submitting for consideration the attached comments from China on proposed rule - Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under the Biologics License Application, and Animal Drugs (WTO G/TBT/N/USA/214).

Please acknowledge receipt of the comments by e-mail: ncsci@nist.gov and anne.meininger@nist.gov.   

Thank you in advance for your consideration of these comments. 

Regards,
Brenda Umberger
__
U.S. WTO TBT Inquiry Point
National Center for Standards and Certification Information (NCSCI)
National Institute of Standards and Technology
Gaithersburg, MD 20899-2100 USA
Telephone: 301-975-4040
Fax: 301-926-1559
E-mail: ncsci@nist.gov